Metrovate is a New Zealand agritech startup developing precision biostimulants that target crop-specific growth responses while minimizing off-target impacts. Founder and chief scientific officer Nikolai Macnee combines molecular biology with machine learning to isolate natural signalling molecules for targeted, biodegradable plant-growth formulations. The company operates a purpose-built lab in the Newmarket Innovation Precinct at the University of Auckland. Current work focuses on validating efficacy, refining an initial targeted product, and conducting further field trials and R&D ahead of commercial scale-up. Metrovate positions its platform as a way to improve crop resilience, speed recovery, and raise yields while reducing reliance on fertilisers, herbicides and pesticides.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

May 2024